Posts by Sandra Ansanay-Alex
Microbiota Symposium
The 11th Microbiota Symposium is taking place on 5 February 2026 in Geneva Join the HUG, in partnership with the University of Geneva, to the 11th Microbiota Symposium, dedicated to exploring clinical and personalized nutrition through discoveries about the gut microbiota.The symposium aims to bring together physicians, scientists, healthcare professionals and industry players with a…
Read MoreGARDP supports the development of Debiopharm’s new potential treatment for gonorrhoea
The Global Antibiotic Research & Development Partnership (GARDP) and the Swiss-based global biopharmaceutical company Debiopharm have signed a memorandum of understanding to develop Debio 1453, a novel compound representing a new antibiotic class that targets Neisseria gonorrhoeae. Multidrug-resistant strains of N. gonorrhoeae have emerged globally, limiting treatment options and elevating this pathogen to…
Read MoreJuvion Health Sciences and Neuria supported by the FIT
FIT announces the granting of two Tech Seed loans worth CHF 100,000 each to two Swiss Health Valley start-ups: Juvion Health Sciences and Neuria. Juvion: maintaining the structure and function of movement circuits to improve mobility One in three people over the age of 60 is affected by reduced mobility. This decline in…
Read MoreAspivix raises 1.95 million euros via crowdfunding campaign
Aspivix, the Swiss start-up behind Carevix™, an innovative device designed to transform gynecological practices, recently launched a crowdfunding campaign that has already raised 1.9 million euros. The initiative aims to bring together a community committed to supporting a technology focused on women’s comfort and health. With 85 investors, the crowdfunding campaign, accessible on…
Read MoreDiverSsiTy SA: Therapy for Adolescents with Autism Spectrum Disorder (ASD)
DiverSsiTy SA leverages Mixed Reality (MR) and Artificial Intelligence (AI) to revolutionise mental health for people with Autism Spectrum Disorder (ASD). The company has developed a personalized therapeutic solution designed to enhance social, emotional, and proprioceptive skills in adolescents with high-functioning autism, ultimately improving their quality of life and social integration. Origins &…
Read MoreSwiss Economic Award
Apply before 30 January for the Swiss Economic Award 2026!
Read MoreA CHF 2 Million Innosuisse Grant for Tune Insight
2025 is off to a groundbreaking start for Tune Insight, a leading EPFL spin-off specializing in privacy-preserving data collaboration solutions. The start-up secured a CHF 2 Million Innosuisse Grant to revolutionise Real-World Evidence (RWE) access for AI in pharma. Despite growing interest in using Real-World Evidence (RWE) to fuel AI innovation in healthcare, access…
Read MoreVandria starts clinical trials for VNA-318
Vandria SA, a Vaud-based start-up at the vanguard of mitochondrial therapeutics developing first-in-class small molecule mitophagy inducers, announced last December that the first subjects have been dosed in its first-in-human clinical trial of its lead Central Nervous System (CNS) compound VNA-318. Readout of this combined single and multiple ascending dose trial is expected in the…
Read MoreBasel Launch
Apply before 7 January 2026 for the Basel Launch programme Basel Launch programme is looking for breakthrough innovations that can form the basis of new biopharma ventures, from all over the world. Therapeutic products or platform projects at any stage, from pre-seed to seed, at the very beginning, or even before, can apply.…
Read MoreAstrocyte and MyoLink supported by FIF
Two Geneva-based life sciences projects have been selected to receive funding through the FONGIT Innovation Fund (FIF). Astrocyte and MyoLink, received a grant and a Seed Loan. MyoLink: Simplifying muscle monitoring for gait rehabilitation MyoLink is addressing unmet needs in gait rehabilitation with a non-invasive, easy-to-set-up system for real-time muscle monitoring. Current tools…
Read More